Carregant...
Reducing Antacid Use in a Level IV NICU: A QI Project to Reduce Morbidity
INTRODUCTION: Gastroesophageal reflux is a physiologic occurrence in infants. Clinicians caring for neonates use histamine-2 receptor antagonists (H2As) or proton pump inhibitors (PPIs) for symptomatic reflux, apnea/bradycardia/desaturations, or irritability. Recent studies have shown that there is...
Guardat en:
| Publicat a: | Pediatr Qual Saf |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Health
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7297399/ https://ncbi.nlm.nih.gov/pubmed/32607459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/pq9.0000000000000303 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|